Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA) Position Lowered by Michelson Medical Research Foundation Inc.

Michelson Medical Research Foundation Inc. lowered its position in Vanguard FTSE Developed Markets ETF (NYSEARCA:VEAFree Report) by 56.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 158,160 shares of the company’s stock after selling 203,000 shares during the quarter. Vanguard FTSE Developed Markets ETF comprises about 6.3% of Michelson Medical Research Foundation Inc.’s portfolio, making the stock its 5th largest position. Michelson Medical Research Foundation Inc.’s holdings in Vanguard FTSE Developed Markets ETF were worth $7,563,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the stock. Sellwood Investment Partners LLC purchased a new position in Vanguard FTSE Developed Markets ETF during the 4th quarter worth approximately $26,000. Decker Retirement Planning Inc. acquired a new stake in Vanguard FTSE Developed Markets ETF in the 4th quarter valued at $29,000. Chapman Financial Group LLC acquired a new stake in Vanguard FTSE Developed Markets ETF during the 4th quarter worth $29,000. Keystone Financial Group Inc. purchased a new position in shares of Vanguard FTSE Developed Markets ETF during the 4th quarter worth $32,000. Finally, Headlands Technologies LLC raised its holdings in Vanguard FTSE Developed Markets ETF by 65.2% in the 4th quarter. Headlands Technologies LLC now owns 702 shares of the company’s stock valued at $34,000 after buying an additional 277 shares during the period.

Vanguard FTSE Developed Markets ETF Price Performance

Shares of NYSEARCA:VEA opened at $53.94 on Tuesday. The firm’s 50-day moving average is $51.29 and its two-hundred day moving average is $50.30. Vanguard FTSE Developed Markets ETF has a 1 year low of $45.14 and a 1 year high of $53.96. The firm has a market capitalization of $153.19 billion, a PE ratio of 15.69 and a beta of 0.86.

About Vanguard FTSE Developed Markets ETF

(Free Report)

The Vanguard Developed Markets Index Fund (VEA) is an exchange-traded fund that mostly invests in total market equity. The fund tracks a market-cap weighted index of large-, mid- and small-cap stocks from developed markets outside the US. VEA was launched on Jul 20, 2007 and is managed by Vanguard.

See Also

Institutional Ownership by Quarter for Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA)

Receive News & Ratings for Vanguard FTSE Developed Markets ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vanguard FTSE Developed Markets ETF and related companies with MarketBeat.com's FREE daily email newsletter.